Saved Results

No results saved yet.

Enter a patient name and hit Save on a result.

HomeInternational Prognostic Index (IPI)
Pin your most used calculators here by clicking the star in the dropdown.

International Prognostic Index (IPI)

Clinical Context & Background

The International Prognostic Index (IPI) was developed to predict the prognosis of patients with aggressive non-Hodgkin lymphoma, specifically Diffuse Large B-Cell Lymphoma (DLBCL). It is calculated based on five adverse prognostic factors.
Primary Source EvidenceThe International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med. 1993;329(14):987-994.
Formula Logic
Sum of risk factors (Age, Stage, LDH, PS, Extranodal).

Reference Data

Risk GroupScore5-Year Overall Survival
Low Risk0 - 173%
Low-Intermediate251%
High-Intermediate343%
High Risk4 - 526%

Share This Calculator

Share:

Related Tools

NCCN-IPI (Lymphoma)CLL-IPIMIPI (Mantle Cell Lymphoma)

Evidence-based oncology decision support. Verify with clinical guidelines.